FTH — Faeth Therapeutics Share News
0.000.00%
Last trade - 00:00- $519.39m
- $332.95m
Brief: Sensei Announces New Preclinical Data For SNS-101
Sensei Biotherapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Sensei Biotherapeutics Reports Second Quarter 2022 Financial Results
Sensei Biotherapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Apeiron Investment Group Ltd Reports 11.2% Stake In Sensei Biotherapeutics
Brief: Sensei Biotherapeutics Appoints Patrick Gallagher As Chief Business Officer
Sensei Biotherapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Sensei Biotherapeutics Reports First Quarter 2022 Financial Results And Recent Business Highlights
Sensei Biotherapeutics Inc expected to post a loss of 35 cents a share - Earnings Preview
Brief: Sensei Biotherapeutics Files For Mixed Shelf Of Upto $150 Million
Brief: Sensei Biotherapeutics Reports Full Year 2021 Financial Results And Business Highlights
Brief: Sensei Biotherapeutics Appoints William Ringo, Mba, As Chair Of Board Of Directors
Brief: Sensei Biotherapeutics Announces Executive Promotions
Brief: Sensei Biotherapeutics Announces Addition To The Nasdaq Biotechnology Index
Brief: Sensei Biotherapeutics Presents Preclinical Data for SNS-101 at SITC 36th Annual Meeting
Brief: Sensei Biotherapeutics Reports Qtrly Net Loss Per Share Of $0.32
Brief: Sensei Biotherapeutics To Present New Data For SNS-101 At The Society For Immunotherapy Of Cancer
Sensei Biotherapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Sensei Biotherapeutics Reports Second Quarter 2021 Results